AAAAAA
Results: 1-25/38
Authors:
Kher, A
Samama, MM
Citation: A. Kher et Mm. Samama, Low-molecular-weight heparins: Weeks or months instead of days of treatment, CL APPL T-H, 7(4), 2001, pp. 314-320
Authors:
Gerotziafas, GT
Elalamy, I
Lecrubier, C
Lebrazi, J
Mirshahi, M
Potevin, F
Lecompte, T
Samama, MM
Citation: Gt. Gerotziafas et al., The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia, BL COAG FIB, 12(7), 2001, pp. 511-520
Authors:
Samama, MM
Citation: Mm. Samama, A century of progress. From biology to antithrombotic drugs., J MAL VASC, 26(3), 2001, pp. 165-168
Authors:
Gouin-Thibault, I
Achkar, A
Samama, MM
Citation: I. Gouin-thibault et al., The thrombophilic state in cancer patients, ACT HAEMAT, 106(1-2), 2001, pp. 33-42
Authors:
Meddahi, S
Bara, L
Fessi, H
Samama, MM
Citation: S. Meddahi et al., Pharmacologic modulation of thrombin generation associated with human clots by human purified antithrombin alone or in the presence of low molecular weight heparin or unfractionated heparin, BL COAG FIB, 11(1), 2000, pp. 51-59
Authors:
Elalamy, I
Lecrubier, C
Horellou, MH
Conard, J
Samama, MM
Citation: I. Elalamy et al., Heparin-induced thrombocytopenia: laboratory diagnosis and management, ANN MED, 32, 2000, pp. 60-67
Authors:
Depasse, F
Gilbert, M
Goret, V
Rolland, N
Samama, MM
Citation: F. Depasse et al., Anti-Xa monitoring: Inter-assay variability, THROMB HAEM, 84(6), 2000, pp. 1122-1123
Authors:
Conard, J
Samama, MM
Citation: J. Conard et Mm. Samama, Oral contraceptives, hormone replacement therapy and haemostasis, CEPHALALGIA, 20(3), 2000, pp. 175-182
Authors:
Warwick, D
Samama, MM
Citation: D. Warwick et Mm. Samama, The contrast between venographic and clinical endpoints in trials of thromboprophylaxis in hip replacement, J BONE-BR V, 82B(4), 2000, pp. 480-482
Authors:
Helft, G
Worthley, SG
Zaman, AG
Samama, MM
Badimon, JJ
Citation: G. Helft et al., Thrombolysis and adjunctive therapies in acute myocardial infarction, HAEMOSTASIS, 30(4), 2000, pp. 159-167
Authors:
Haas, S
Marder, VJ
Samama, MM
Citation: S. Haas et al., Conclusion, HAEMOSTASIS, 30, 2000, pp. 175-176
Authors:
Haas, S
Marder, VJ
Samama, MM
Citation: S. Haas et al., Thromboembolism: New insights and future prospects - Proceedings of the 7th International Symposium on Thromboembolic Diseases - Palma de Mallorca, June 9-10, 2000 - Preface, HAEMOSTASIS, 30, 2000, pp. VII-VII
Authors:
Samama, MM
Elalamy, I
Citation: Mm. Samama et I. Elalamy, Aspirin and hemostasis., REV MED IN, 21, 2000, pp. 27S-34S
Authors:
Torbicki, A
van Beek, EJR
Charbonnier, B
Meyer, G
Morpurgo, M
Palla, A
Perrier, A
Galie, N
Gorge, G
Herold, C
Husted, S
Jezek, V
Kasper, W
Kneussl, M
Morice, AH
Musset, D
Samama, MM
Simonneau, G
Sors, H
de Swiet, M
Turina, M
Kronik, G
Widimsky, J
Citation: A. Torbicki et al., Guidelines on diagnosis and management of acute pulmonary embolism, EUR HEART J, 21(16), 2000, pp. 1301-1336
Authors:
Samama, MM
Gerotziafas, GT
Citation: Mm. Samama et Gt. Gerotziafas, Comparative pharmacokinetics of LMWHs, SEM THROMB, 26, 2000, pp. 31-38
Authors:
Samama, MM
Cohen, AT
Leizorovicz, A
Citation: Mm. Samama et al., Enoxaparin for the prevention of venous thromboembolism - Reply, N ENG J MED, 342(2), 2000, pp. 137-137
Authors:
Gerotziafas, GT
Samama, MM
Citation: Gt. Gerotziafas et Mm. Samama, On the mechanism of inhibition of factor VIIa by synthetic pentasaccharide, low-molecular-weight heparins and unfractionated heparin, BR J HAEM, 109(4), 2000, pp. 903-905
Authors:
Samama, MM
Citation: Mm. Samama, An epidemiologic study of risk factors for deep vein thrombosis in medicaloutpatients - The sirius study, ARCH IN MED, 160(22), 2000, pp. 3415-3420
Authors:
Samama, MM
Desnoyers, P
Gerotziafas, GT
Citation: Mm. Samama et al., Low molecular weight heparins: a comparative review of pharmacodynamic, clinical pharmacology, THROMBOSIS AND ANTITHROMBOTIC THERAPY, 2000, pp. 71-96
Authors:
Planes, A
Samama, MM
Citation: A. Planes et Mm. Samama, Unfractionated heparin, low molecular weight heparins and heparinoid in orthopedic and trauma surgery, THROMBOSIS AND ANTITHROMBOTIC THERAPY, 2000, pp. 97-124
Authors:
Gerotziafas, GT
Samama, MM
Citation: Gt. Gerotziafas et Mm. Samama, Efficacy and safety of low molecular weight heparins in the prevention of venous thromboembolism in general surgery, THROMBOSIS AND ANTITHROMBOTIC THERAPY, 2000, pp. 125-143
Authors:
Gerotziafas, G
Samama, MM
Citation: G. Gerotziafas et Mm. Samama, Alternatives to platelet transfusion, PLATELET THERAPY: CURRENT STATUS AND FUTURE TRENDS, 2000, pp. 363-381
Authors:
Samama, MM
Citation: Mm. Samama, Applying risk assessment models in general surgery: effective risk stratification, BL COAG FIB, 10, 1999, pp. S79-S84
Authors:
Cohen, AT
Gallus, AS
Haas, S
Monreal, M
Pini, M
Samama, MM
Citation: At. Cohen et al., Workshop I: The potential role of new therapies in deep vein thrombosis prophylaxis, BL COAG FIB, 10, 1999, pp. S99-S102
Authors:
Achkar, A
Samama, MM
Citation: A. Achkar et Mm. Samama, How to manage outpatients with deep vein thrombosis?, J MAL VASC, 24(1), 1999, pp. 58-65